Stay updated on APL-501 with APL-101 in HCC and RCC Clinical Trial
Sign up to get notified when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.

Latest updates to the APL-501 with APL-101 in HCC and RCC Clinical Trial page
- Check5 days agoChange DetectedRevision information in the page footer changed from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedLocations section updated to include Australian sites (New South Wales, South Australia, Victoria, Western Australia) with revision v3.3.3. The HHS Vulnerability Disclosure link and older location entries were removed.SummaryDifference0.6%

- Check55 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; this is a minor internal change and no study content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the general notice about a lapse in government funding and potential updates on ClinicalTrials.gov. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check77 days agoChange DetectedNo noticeable changes between the two screenshots; page layout and content appear unchanged.SummaryDifference0.4%

- Check105 days agoChange Detected- Updated notice about government funding and operating status; NI H Clinical Center info and links added. - Version updated from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to APL-501 with APL-101 in HCC and RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.